High-dose naloxone (1.0 Mg/kg): Psychological and endocrine effects in normal male subjects pretreated with one milligram of dexamethasone

Psychoneuroendocrinology

Volumn 23, Issue 4, 1998, Pages 413-424

  Martin Del Campo A F ^a   Cortes Sotres J ^a   Herrera Ferrá, Karen ^a   Ulloa Aguirre, A ^b  

^a Dept of Psico Neuroendocrinology   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cortisol; Dexamethasone; Endocrine; Humans; Mood; Naloxone

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; NALOXONE; OPIATE; PLACEBO;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSPHORIA; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; NEGATIVE FEEDBACK; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFFECT; CROSS-OVER STUDIES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEEDBACK; GLUCOCORTICOIDS; HEART RATE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; PREMEDICATION; REFERENCE VALUES;

EID: 0344043392     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(98)00002-X     Document Type: Article

References (36)

1. Al-Damluji S., Cunnah D., Perry L., Grossman A., Besser G. M. (1987) The effect of alpha adrenergic manipulation of the 24 hour pattern of cortisol secretion in man. Clinical Endocrinology 26, 61-66.
2. Armitage P., Berry G. (1994) Statistical Methods in Medical Research, Third Edition. Cambridge, MA, pp. 331-332.
3. Brennemann W., Stitz B., Van Ahlen H., Brensing K. A., Klingmüller D. (1993) Treatment of idiopathic erectile dysfunction in men with opiate antagonist naltrexone - A double-blind study. Journal of Andrology 14, 407-410.
4. Carroll B. J., Feinberg M., Greden J. F., Tarika J., Albala A. A., Haskett R. F., James N., Kromfol Z., Lohr N., Steiner M., deVigne J. P., Young E. (1981) A specific laboratory test for the diagnosis of melancholia:S tandarization, validation, and clinical utility. Archives of General Psychiatry 38, 15-22.
5. Cohen M. R., Cohen R. M., Pickar D., Weingartner H., Murphy D. L. (1983) High-dose naloxone infusion to normals. Archives of General Psychiatry 40, 613-619.
6. Conaglen J. V., Donald R. A., Espiner E. A., Livesey J. H., Nicholls M. G. (1985) Effect of naloxone in the hormone response to CRF in man. Endocrine Research 11, 39-44.
7. Copinshi G., Beyloos M., Booson D., Desir D., Goldstein J., Robyn C., Linkowski P., Mendelwicz J., Franckson J. (1983) Immediate and delayed alterations of adrenocorticotropin and cortisol in normal man. Journal of Clinical Endocrinology and Metabolism 57, 1287-1291.
8. Ehrenreich H., Kolmar C., Muller O. A., Goebel F. D. (1987) Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist. Klinische Wochenschrift 65, 453-457.
9. Eysenck H. J., Eysenck S. B. G. (1975) Manual of the Eysenck Personality Questionnaire. Hodder and Stoughton, London.
10. García-Rubí E., Vázquez-Alemán D., Méndez J. P., Salinas J. L., Garza-Flores J., Ponce-de-León S., Pérez-Palacios G., Ulloa-Aguirre A. (1992) The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery. Clinical Endocrinology 37, 520-528.
11. Garland E. J., Zis A. P. (1990) Effect of vasopressin and naloxone alone and in combination on cortisol secretion after dexamethasone pretreatment. Hormone Research 34, 249-253.
12. Gold P. W., Loriaux D. L., Roy A., Kling M. A., Colabrese J. R., Kellman C. H., Nieman L. K., Post R. M., Pickar D., Galluci W., Avgerinos P., Paul, Oldfield E. H., Cutler Jr G. B., Chrousos G. P. (1986) Responses to corticotropin-releasing hormone in the hypercorticolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. New England Journal of Medicine 314, 1329-1335.
13. Grossman A. B., Moult P., Gaillard R. C., Delitala G., Toff W. D., Rees L. H., Besser G. M. (1981) The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone. Clinical Endocrinology (Oxford) 14, 41-47.
14. Gustafsson J. -A., Carlstedt-Duke J., Poellinger L., Okret S., Wikstrom A. -Ch, Bronnegard M., Gillner M., Dong Y., Fuxe K., Cintra A., Harfstrand A., Agnati L. (1987) Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocrine Review 8, 185-234.
15. Hermus A. R. M. M., Pieters G. F. F. M., Pesman G. J., Hofman J., Smal A. G. H., Benraad T. H. J., Kloppenborg P. W. C. (1987) Escape from dexamethasone-induced ACTH and cortisol supression by corticotrophin-releasing hormone: modulatory effect of basal dexamethasone levels. Clinical Endocrinology 26, 67-79.
16. Hohnloser J., Von Werder K., Muller O.A. (1989) Acute dexamethasone suppression of ACTH secretion stimulated by human corticotropin releasing hormone, AVP, and by hypoglycemia. Clinical Endocrinology 31, 175-184.
17. Holsboer F., von Bardeleben U., Wiedeman K., Miller O. A., Stalla G. K. (1987) Serial assesment of corticotropin releasing hormone response after dexamethasone in depression. Biological Psychiatry 22, 228-234.
18. Kumor K. M., Haertzen C. A., Jasinski D. R., Johnson R. E. (1988) The psychopharmacologic and prolactin response after large doses of naloxone in man. Pharmacology Biochemistry and Behaviour 30, 967.
19. Lytras N., Grossman A., Perry L., Tomlin S., Wass J., Coy D., Schally A., Rees L., Besser G. (1984) Corticotrophin-releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clinical Endocrinology 20, 71-84.
20. Martín del Campo A. F., McMurray R., Besser L., Grossman A. (1992) Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biological Psychiatry 32, 344.
21. Martín del Campo A. F., Dowson J. H., Herbert J., Paykel E. S. (1994) The effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology 114, 583-590.
22. Martín del Campo A. F. (1996) Construcción y Validación de la Escala de Perfil Afectivo. Revista Salud Mental (Suppl) 19, 36-38.
23. McMurray R. G., Newbould E., Boulous P., Besser G. M. Grossman A. (1991) High-dose naloxone modifies cardiovascular and neurendocrine function in ambulant subjects. Psychoneuroendocrinology 16, 447-455.
24. Naber D., Sand P., Heigl B. (1996) Psychopathological and neuropsychological effects of 8 days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21, 25-31.
25. Pfaus J. G., Gorzalka B. B. (1987) Opioids and Sexual Behavior. Neuroscience and Biobehavioral Review 11, 1-34.
26. Pickar D., Cohen M. R., Naber D., Cohen R. M. (1982) Clinical studies of the endogenous opioid system. Biological Psychiatry 17, 1243-1276.
27. Plihal W., Krug R., Pietrowsky R., Fehm H. L., Born J. (1996) Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 21, 515-524.
28. Stokes P. E., Stoll P. M., Koslow S. H., Maas J. W., Davis J. M., Swan A. C., Robins E. (1984) Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Archives of General Psychiatry 41, 257-267.
29. Stubbs W. A., Jones A., Edwards C. R. W., Delitala G., Jeffcoate W. J., Ratter S. J. (1978) Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2, 1225-1227.
30. Suemara S., Dallman M. F., Darlington D. N., Cascio C. S., Shinsako J. (1989) Role of alpha-adrnergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendocrinology 49, 181-190.
31. Tsagarakis S., Rees L. H., Besser M., Grossman A. (1990) Opiate receptor regulation of CRF-41 release from rat hypothalamus in vitro. Neuroendocrinology 51, 599.
32. van Wimersma Greidanus TB and Grossman AB (1991) "Opioid regulation of pituitary function". Progress in Sensory Physiology 12, 1-64.
33. von Bardeleben U., Holsboer F., Stalla G. K., Muller O. A. (1985) Combined administration of human corticotropin-releasing factor and vasopressin induces cortisol escape from dexamethasone supression in healthy subjects. Life Sciences 37, 1613-1618.
34. Willer J. C., Boureau F., Dauthier C., Bonora M. (1979) Study of naloxone in normal awake man: effects on heart rate and respiration. Neuropharmacology 18, 469-472.
35. Wolkowitz O. M. (1994) Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19, 233-255.
36. Zelis R., Mansour R., Capone R., Mason D. (1994) The cardiovascular effects of morphine: the peripheral capacitance and resistance vessels in human subjects. Journal of Clinical Investigation 54, 1247-1258.